Filtered By:
Condition: Anaphylactic Shock
Drug: Beta-Blockers
This page shows you your search results in order of date.
Order by Relevance | Date
Total 24 results found since Jan 2013.
Perioperative aspects of anaphylaxis
Orv Hetil. 2023 Jun 4;164(22):871-877. doi: 10.1556/650.2023.32789. Print 2023 Jun 4.ABSTRACTAnaphylaxis is a generalized, severe, life-threatening reaction, mostly with an allergic origin. Triggers are usually drugs, insect bites, poisons, contrast material and food. It is caused by various mediators (histamine, prostaglandins, leukotrienes etc.) released from mast cells, basophilic granulocytes. Histamine plays a central role in its creation. Immediate recognition and specific treatment instantaneously are essential for successful treatment. In severe conditions, the clinical features are very similar, regardless of thei...
Source: Orvosi Hetilap - June 4, 2023 Category: General Medicine Authors: Bal ázs Sütő Kamilla Domokos Source Type: research
Knowledge Gaps in the Diagnosis and Management of Anaphylaxis
Ann Allergy Asthma Immunol. 2023 May 18:S1081-1206(23)00336-8. doi: 10.1016/j.anai.2023.05.010. Online ahead of print.ABSTRACTKnowledge gaps in the diagnosis and treatment of anaphylaxis impede the clinician's ability to effectively manage patients with anaphylaxis. This review will emphasize the lack of a global consensus on defining and determining the severity of anaphylaxis; the need for validating biomarkers used for diagnosing anaphylaxis; and data collection deficiencies. Perioperative anaphylaxis has a wide differential diagnosis, often requires treatment beyond epinephrine, and poses a challenge for the clinician ...
Source: Annals of Allergy, Asthma and Immunology - May 20, 2023 Category: Allergy & Immunology Authors: Dana V Wallace Source Type: research
Choice of Pharmacotherapy for Heart Failure in Patients Undergoing Venom Immunotherapy
In this study, we evaluated the relationship between VIT failure and the use of BBs and ACE inhibitors.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Sahana Venkatesh, Kamil Salam, Vaskar Mukerji Source Type: research
Effects of Prescription Medications on Clinical Outcomes in Adults Presenting with Anaphylaxis
Certain medications may have negative effects on anaphylaxis outcomes. We aimed to assess the effects of non-steroidal anti-inflammatory drugs (NSAIDs), tricyclic antidepressants (TCAs), beta-blockers, and angiotensin receptor blockers (ARBs) in adults presenting with anaphylaxis to emergency departments (EDs).
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Daniel Sehayek, Ann Clarke, Elissa Abrams, Adam Bretholz, Edmond Chan, Derek Chu, Jennifer Gerdts, Ran Goldman, Elana Hochstadter, Rodrick Lim, Christine McCusker, Jocelyn Moisan, Judy Morris, Andrew O ’Keefe, Jennifer Protudjer, Elinor Simons, Julia Up Source Type: research
Stuck between a block and a hard place: vaccine-hypersensitivity testing in children with cardiac disease
Vaccine-associated anaphylaxis (VAA) is rare with an estimated 1.3 cases per 1 million doses administered. Though rare, VAA can cause vaccine hesitancy. Congenital heart disease patients are at greater risk for poor outcomes from vaccine-preventable infections; however, the use of beta-blockers and ACE inhibitors in these patients further complicates VAA testing and management. Such patients require prompt, careful risk-benefit analysis when formally evaluating VAA.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2022 Category: Allergy & Immunology Authors: R. Rana, D. Nguyen, V. Szafron, S. Nicholas, S. Anvari Tags: M049 Source Type: research
Effect of Prescription Drugs on Anaphylaxis Severity and Symptoms
Anaphylactic reactions are medical emergencies presenting with varying levels of severity, which may be influenced by drug intake. We aimed to assess the severity of anaphylaxis in patients taking statins, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, tricyclic antidepressants as well as proton-pump inhibitors.
Source: Journal of Allergy and Clinical Immunology - February 1, 2021 Category: Allergy & Immunology Authors: Sofianne Gabrielli, Ann Clarke, Judy Morris, Jocelyn Gravel, Rodrick Lim, Edmond Chan, Ran Goldman, Andrew O, Jennifer Gerdts, Derek Chu, Julia Upton, Adam Bretholz, Christine McCusker, Xun Zhang, Moshe Ben-Shoshan, Laura May Miles Source Type: research
Negative Penicillin Skin Testing Induced Anaphylaxis with Concurrent Beta Blocker and Angiotensin-converting Enzyme Inhibitor Use
We present the first case of anaphylaxis following negative skin prick and intradermal tests with penicillin and benzylpenicilloyl polylysine.
Source: Annals of Allergy, Asthma and Immunology - December 30, 2020 Category: Allergy & Immunology Authors: Phuong Daniels, Maaz Jalil, Chelsea Michaud, Robert Hostoffer Tags: Letters Source Type: research
ACEIs and beta blockers as a risk factor for severe reactions to Hymenoptera venom, facts or fictions?
The article by Francuzik et al,1 “Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry,” recently published in the journal raises the controversial issue that angiotensin-converting enzyme inhibitors (ACEIs) and β-blockers may increase the risk of severe reac tions to Hymenoptera venom. Such risk has been initially suggested by Stumpf et al2 in 2006 by the results of a number of case reports, but was denied by others.3,4 The latest European Academy of Allergy and Clinical Immunology guidelines on venom immunotherapy (VIT) stated that the risk from ACEIs ...
Source: Journal of Allergy and Clinical Immunology - November 23, 2020 Category: Allergy & Immunology Authors: Cristoforo Incorvaia, Stefano Pucci, Oreste C. Febo Tags: Correspondence Source Type: research
